Step 8 of 10 · Decision support
Treatment plan
What this step shows
The recommended next treatment step, following statin → ezetimibe → PCSK9 inhibitor and taking intolerance and time on therapy into account.
Clinical pathway
Secondary Prevention
Risk category
Very High
LDL-C target
<1.4 mmol/L
Recommended next step
At target — continue current therapy and monitor
LDL-C is already below target on the current regimen. No escalation needed; recommend routine monitoring.
Current therapy on record
Low-intensity statin (80) + ezetimibe · 1 month(s) on this regimen
Edit
How this was decided
- ✓ LDL-C already at target? 0.5 mmol/L vs. target <1.4 mmol/L.